A detailed history of Ifp Advisors, Inc transactions in Care Dx, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 20 shares of CDNA stock, worth $378. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20
Holding current value
$378
% of portfolio
0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 04, 2025

BUY
$20.4 - $32.2 $408 - $644
20 New
20 $0
Q4 2022

Feb 07, 2023

SELL
$10.88 - $20.05 $250 - $461
-23 Reduced 6.34%
340 $5,000
Q2 2022

Sep 06, 2022

BUY
$20.49 - $39.72 $7,437 - $14,418
363 New
363 $6,000
Q2 2022

Aug 12, 2022

SELL
$20.49 - $39.72 $7,437 - $14,418
-363 Closed
0 $0
Q1 2022

Sep 06, 2022

BUY
$28.19 - $46.6 $648 - $1,071
23 Added 6.76%
363 $13,000
Q3 2021

Oct 06, 2021

SELL
$59.15 - $91.99 $9,464 - $14,718
-160 Reduced 32.0%
340 $22,000
Q2 2021

Jul 13, 2021

SELL
$63.02 - $95.11 $63 - $95
-1 Reduced 0.2%
500 $46,000
Q1 2021

Apr 30, 2021

BUY
$57.62 - $95.6 $28,694 - $47,608
498 Added 16600.0%
501 $34,000
Q4 2020

Jan 25, 2021

SELL
$41.43 - $77.09 $207 - $385
-5 Reduced 62.5%
3 $0
Q3 2020

Oct 29, 2020

BUY
$30.88 - $37.94 $247 - $303
8 New
8 $0
Q2 2020

Aug 05, 2020

BUY
$18.95 - $35.43 $0 - $0
0 New
0 $0
Q1 2020

May 12, 2020

BUY
$13.94 - $28.25 $0 - $0
0 New
0 $0
Q4 2019

Jan 17, 2020

BUY
$19.24 - $28.41 $0 - $0
0 New
0 $0
Q3 2019

Nov 07, 2019

SELL
$20.03 - $40.08 $20,030 - $40,080
-1,000 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$22.09 - $39.21 $86,151 - $152,919
-3,900 Reduced 79.59%
1,000 $32,000
Q4 2018

Jan 23, 2019

SELL
$19.89 - $30.02 $103,428 - $156,104
-5,200 Reduced 51.49%
4,900 $123,000
Q3 2018

Oct 25, 2018

BUY
$12.1 - $28.85 $12,100 - $28,850
1,000 Added 10.99%
10,100 $0
Q2 2018

Aug 07, 2018

BUY
$7.93 - $15.79 $64,233 - $127,899
8,100 Added 810.0%
9,100 $0
Q1 2016

Jun 03, 2019

BUY
N/A
1,000
1,000 $32,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.01B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.